The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000513314
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
11/03/2026
Date registered
Help: Date registered
24/04/2026
Date last updated
Help: Date last updated
24/04/2026
Date data sharing statement initially provided
Help: Data sharing statement date
24/04/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
PREDICT-DL: Performance of Paediatric Real-time Emergency Department admission and Inpatient Care Time prediction with Deep Learning
Scientific title
PREDICT-DL: Performance of Paediatric Real-time Emergency Department admission and Inpatient Care Time prediction with Deep Learning
Additional trial identifiers [1] 316761 0
None
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Emergency Medicine 341061 0
Patient flow 341062 0
Condition category
Condition code
Public Health 337186 337186 0 0
Health service research
Emergency medicine 337560 337560 0 0
Other emergency care

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Patient flow prediction modelling with machine learning using triage data. Machine learning will use a ensemble model of XGboost, multilayer perceptron and TabNET with a logistic regression blend and natural language processing to interpret and embed the triage free text.
Outcomes of patient flow predicted are admission from ED, with short stay vs medical vs surgical admissions to also be predicted, as well as the length of stay.
The study will use the previous 5 years of data for training and simulation prior to the intervention, with the intervention then using 6 months of live prospective data. During this time, the bed managers who receive the model outputs will be involved in qualitative interviews as an additional outcome and source of data.
Bed manages will receive hourly predictions (with confidence intervals) on a digital bed occupancy dashboard and they will receive training in how these predictions are created and what they mean via educational sessions and a reference guide available at the time of use. This dashboard is already in clinical use, it just does not provide any ahead of time predictions. It is intended that this can help inform their capacity planning, though resource allocation ahead of the time of actual admission. This will given them information from the time of a patients triage, giving them valuable lead time, but the system will not suggest how to change capacity planning, it will only provide predictions of what the bed demand will be in the upcoming hours. There is no quantitative method of assessing adherence or click through based on system limitations, though assessment will occur via qualitative interviews both early and late in the intervention.
Intervention code [1] 333447 0
Early detection / Screening
Description of the comparator or control
No control group.
Control group
Uncontrolled

Outcomes
Primary outcome [1] 344699 0
Model performance in predicting the required number of beds (admissions) as a composite of both discrimination and calibration metrics below.
Timepoint [1] 344699 0
Hourly measurements and assessed over a 6 month intervention period.
Primary outcome [2] 345148 0
Prediction of length of stay (LOS - AKA care time) accuracy
Timepoint [2] 345148 0
Hourly across the study the value will be recorded and stored, then the rolling and absolute mean will be reported.
Secondary outcome [1] 458938 0
Qualitative assessment of tool usefulness
Timepoint [1] 458938 0
One interview with each consenting staff member between the 1 to 2 month mark (range due to multiple interviews) and another interview with each staff member at the conclusion of the study, with all exit interviews to occur within two months of the conclusion of the intervention.

Eligibility
Key inclusion criteria
All presentations to the hospital.
Minimum age
0 Years
Maximum age
20 Years
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Nil.

Study design
Purpose of the study
Prevention
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis
Time series of performance metrics, SHAP feature importance, covariate drift, concept drift analysis and qualitative analysis.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
WA

Funding & Sponsors
Funding source category [1] 321358 0
University
Name [1] 321358 0
University of Notre Dame, Australia
Country [1] 321358 0
Australia
Primary sponsor type
Individual
Name
Dr Ethan Williams, PhD Candidate at the University of Notre Dame Australia and Medical Doctor at the Child and Adolescent Health Service, WA
Address
Country
Australia
Secondary sponsor category [1] 324098 0
University
Name [1] 324098 0
University of Notre Dame, Australia
Address [1] 324098 0
Country [1] 324098 0
Australia
Secondary sponsor category [2] 324330 0
Charities/Societies/Foundations
Name [2] 324330 0
Stan Perron Charitable Foundation
Address [2] 324330 0
Country [2] 324330 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 319892 0
Child and Adolescent Health Service Human Research Ethics Committee
Ethics committee address [1] 319892 0
Ethics committee country [1] 319892 0
Australia
Date submitted for ethics approval [1] 319892 0
20/10/2025
Approval date [1] 319892 0
10/03/2026
Ethics approval number [1] 319892 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 148750 0
Dr Ethan Williams
Address 148750 0
Notre Dame Fremantle, School of Medicine, 32 Mouat St, Fremantle WA 6160
Country 148750 0
Australia
Phone 148750 0
+610434032522
Fax 148750 0
Email 148750 0
Contact person for public queries
Name 148751 0
Ethan Williams
Address 148751 0
Notre Dame Fremantle, School of Medicine, 32 Mouat St, Fremantle WA 6160
Country 148751 0
Australia
Phone 148751 0
+610864562222
Fax 148751 0
Email 148751 0
Contact person for scientific queries
Name 148752 0
Ethan Williams
Address 148752 0
Notre Dame Fremantle, School of Medicine, 32 Mouat St, Fremantle WA 6160
Country 148752 0
Australia
Phone 148752 0
+610864562222
Fax 148752 0
Email 148752 0

Data sharing statement
Will the study consider sharing individual participant data?
No
No IPD sharing reason/comment: Patient data is not to be stored beyond the study as it will continue to be stored by the hospitals records team. Access to the patient data is only available on request to the ethics committee and relevant data custodians and this is not up to the discretion of the research team. The research team is happy to advise on the specifics of data requests for any other research teams.



What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.